Slimming, Singapore (SG)
Slimming, Singapore (SG) @singaporeslimming_com: Medical slimming, weight/fat loss/management/reduction, diet program/medication clinic, Singapore
Join our weight loss program to manage your obesity. For effective slimming and weight management. Choose our weight loss clinic. The weight management clinic with the program that is most likely able to help you achieve your goals.
Aesthetic services available:
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Slimming, Singapore (SG)
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Health Behaviour and Body Mass Index Among Problem Gamblers: Results from a Nationwide Survey
Fri, 22 May 2015 05:40:29 +0100 | Journal of Gambling Studies
The objective of this study was to investigate whether past year problem gamblers differed from non-problem gamblers with regard to health behaviour and body mass index (BMI) among Danes aged 16 years or older. Data were derived from the Danish Health and Morbidity Surveys in 2005 and 2010. Past year problem gambling was defined using the lie/bet questionnaire. Logistic regression analyses were used to examine the association between past year problem gambling and health behaviour and BMI. Problem gambling was associated with unhealthy behaviour and obesity. The odds of smoking was significantly higher among problem gamblers than among non-problem gamblers. Further, the odds of high-risk alcohol drinking and illicit drug use were significantly higher among problem gamblers. The prevalence...
This Is What Happens After You Die
Fri, 22 May 2015 00:09:33 +0100 | Healthy Living - The Huffington Post
(Photo: © Lightning + Kinglyface and Jess Bonham)
Perception and evaluation of women’s bodies in adolescents and adults with anorexia nervosa
Fri, 22 May 2015 00:00:00 +0100 | European Archives of Psychiatry and Clinical Neuroscience
Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation
Fri, 22 May 2015 00:00:00 +0100 | Nanomedicine: Nanotechnology, Biology and Medicine
Publication date: Available online 21 May 2015 Source:Nanomedicine: Nanotechnology, Biology and Medicine Author(s): Antonella Rocca , Stefania Moscato , Francesca Ronca , Simone Nitti , Virgilio Mattoli , Mario Giorgi , Gianni Ciofani Obesity is a worldwide pathological condition that strongly impairs human health, and, to date, no effective therapy against excessive fat accumulation has been found yet. Since overweight correlates with an increased oxidative stress, our aim is to investigate the antioxidant effects of cerium oxide nanoparticles (nanoceria) as a potential pharmaceutical approach for the treatment of obesity. Nanoceria were tested both in vitro and in vivo; they were proven to interfere with the adipogenic pathway by reducing the mRNA transcription of genes involved in adi...
Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years.
Thu, 21 May 2015 23:54:06 +0100 | Diabetes Metab
The objectives of the present work are to evaluate long-term benefit of nonexcitatory gastric electrical stimulation (GES) by the DIAMOND(®) device on glycemic control and body weight in patients with type 2 diabetes inadequately controlled with oral agents and to determine the magnitude of the modulating effects of fasting plasma triglyceride (FTG) levels on these effects of GES. Sixty one patients with type 2 diabetes [HbA1c>7.0% (53 mmol/mol) to<10.5% (91 mmol/mol)] were implanted with the DIAMOND(®) GES device and treated with meal-mediated antral electrical stimulation for up to 36 months. The effects of baseline HbA1c and FTG on glycemic control, body weight, and systolic blood pressure were measured. GES reduced mean HbA1c by 0.9% and body weight by 5.7%. The effects wer...
Persistent organic pollutants as risk factors for type 2 diabetes.
Thu, 21 May 2015 23:54:04 +0100 | Diabetes Metab
Authors: Ngwa EN, Kengne AP, Tiedeu-Atogho B, Mofo-Mato EP, Sobngwi E
Shift work and its association with metabolic disorders.
Thu, 21 May 2015 23:54:03 +0100 | Diabetes Metab
Authors: Brum MC, Filho FF, Schnorr CC, Bottega GB, Rodrigues TC
What Is Saxenda, the New 'Blockbuster' Weight Loss Medication?
Thu, 21 May 2015 22:09:45 +0100 | Healthy Living - The Huffington Post
There is a new "blockbuster" weight loss drug on the market, Saxenda, and it is available in many U.S. pharmacies this month. It is perhaps the most important weight loss medication ever developed. Novo Nordisk Inc., a very big and very old Danish pharmaceutical company, has launched the new drug after months of anticipation by consumers, clinicians and market watchers.
Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study.
Thu, 21 May 2015 21:30:03 +0100 | Current Drug Safety
CONCLUSION: Male patients who are obese at any point during treatment and older at treatment commencement may be the most vulnerable to adverse CV and metabolic events. While future studies using a matched case-control design may be required to verify these findings, we recommend that treating clinicians consider these risks when assessing patient suitability to clozapine therapy.
Effect of the Healthy Schools Program on Prevalence of Overweight and Obesity in California Schools, 2006–2012
Thu, 21 May 2015 19:18:00 +0100 | CDC Preventing Chronic Disease
(Source: CDC Preventing Chronic Disease)